Publicación:
Disease-mongering through clinical trials

Vista sencilla de ítem
dc.contributor.authorGonzález Moreno, María
dc.contributor.authorSaborido Alejandro, Cristian
dc.contributor.authorTeira Serrano, David
dc.date.accessioned2024-05-21T12:53:15Z
dc.date.available2024-05-21T12:53:15Z
dc.date.issued2015
dc.description.abstractOur goal in this paper is to articulate a precise concept of at least a certain kind of disease-mongering, showing how pharmaceutical marketing can commercially exploit certain diseases when their best definition is given through the success of a treatment in a clinical trial. We distinguish two types of disease-mongering according to the way they exploit the definition of the trial population for marketing purposes. We argue that behind these two forms of disease-mongering there are two well-known problems in the statistical methodology of clinical trials (the reference class problem and the distinction between statistical and clinical significance). Overcoming them is far from simpleen
dc.description.versionversión final
dc.identifier.urihttps://hdl.handle.net/20.500.14468/19424
dc.journal.titleStudies in History and Philosophy of Biological and Biomedical Sciences
dc.language.isoen
dc.relation.centerFacultad de Filosofía
dc.relation.departmentLógica, Historia y Filosofía de la Ciencia
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subject.keywordsdisease-mongering
dc.subject.keywordsclinical trials
dc.subject.keywordsvalium
dc.subject.keywordsstatins
dc.titleDisease-mongering through clinical trialses
dc.typejournal articleen
dc.typeartículoes
dspace.entity.typePublication
relation.isAuthorOfPublicationa5e9e774-e1e9-4d08-b1be-bb1da2c210e9
relation.isAuthorOfPublicationad2bda75-c33c-48e1-aad8-c7eb3cfc04cb
relation.isAuthorOfPublication.latestForDiscoverya5e9e774-e1e9-4d08-b1be-bb1da2c210e9
Archivos
Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
DiseaseMongeringFinalVersion.pdf
Tamaño:
316.74 KB
Formato:
Adobe Portable Document Format
Descargar
Colecciones
Artículos y papers